Navigation Links
Clinical Trials Offices Changing Academic Health Center Research Infrastructure
Date:8/27/2009

Strategic Examination and Consolidation of Services Recommended by the AAHC

WASHINGTON, Aug. 27 /PRNewswire-USNewswire/ -- Little uniformity exists in the structure or functions of clinical trials offices, and models are needed for the future, according to Clinical Trials Offices: What's New in Research Administration?, a new report from the Association of Academic Health Centers (AAHC). Emerging centralized clinical trial offices (CTOs) are among the newest developments within the research administration infrastructure of academic health centers -- where leaders are focused on optimizing resources and developing strategies to sustain and transform the nation's research enterprise. The report notes that a trend towards consolidation or centralization in the administration of clinical trial functions has been ongoing for several years -- but is far from accomplished.

Report authors, Elaine Rubin, AAHC vice president for policy and program, and Danielle Lazar, AAHC program associate, profiled eight academic health centers, addressing the development, organization, structure, and activities of the clinical trials office (CTO). Operating budgets of profiled CTOs ranged from $400 thousand to over $4 million with compliance responsibilities that ranged from contracting and cost analysis to education and training.

The report not only provides important insights on the strategies and initiatives to create systems for the future but also institutional cultural change and the challenges that academic health center leaders face to ensure the research enterprise evolves to address new scientific developments, translational research, and interdisciplinary, multisite research.

Study findings reveal that many institutions are still stressed and challenged by the lack of a clearly defined organization and governance structure for clinical trials administration. "Academic health center leaders should examine the organization and structure for clinical trials administration within their respective institutions and determine what, if any, changes are needed to consolidate and optimize the research infrastructure," said Dr. Rubin, who also pointed out that important tools, such as the AAHC's Clinical Trials Administration Toolkit, exist to help with this process.

The AAHC is a national non-profit association dedicated to advancing the nation's health and well-being through the vigorous leadership of academic health centers.


'/>"/>
SOURCE Association of Academic Health Centers
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
9. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
10. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
Breaking Biology News(10 mins):